CD40 COSTIMULATION AND TRANSPLANTATION
CD40 联合刺激和移植
基本信息
- 批准号:6626350
- 负责人:
- 金额:$ 27.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-01-01 至 2003-12-31
- 项目状态:已结题
- 来源:
- 关键词:CD40 molecule T lymphocyte apoptosis biological signal transduction cytokine gene expression genetically modified animals heart transplantation homologous transplantation laboratory mouse leukocyte activation /transformation lymphocyte proliferation nuclear factor kappa beta transplant rejection transplantation immunology tumor necrosis factor alpha
项目摘要
DESCRIPTION: (adapted from applicant's abstract)
Following transplantation, acute rejection is recognized as the most
frequent serious complication and the best predictor of chronic
rejection, a major cause of long term graft loss. T cells are essential
for initiating and maintaining acute rejection. Early intervention in
transplant rejection necessitates understanding the mechanisms of T cell
activation, as related to allograft survival. The principal investigator
and others have found that blockade of CD40 signals prolongs graft
survival. The goal of this proposal is to determine which CD40 regulated
functions mediate graft rejection. CD40 signals are transduced by both
NF-kB-dependent and -independent mechanisms. The PI has found that in
vivo inhibition of NF-kB activation with a dominant negative transgene
or by deletion of c-Rel prolongs allograft survival. Thus, one focus
will be on the role of CD40-regulated actions that are NF-kB-dependent.
The investigators propose the hypothesis that blockade of the CD40/CD40L
costimulatory pathway prolongs allograft survival by NF-kB-dependent
mechanisms. To test this hypothesis, they will employ an adoptive
transfer model of cardiac transplantation using double transgenic lines
that express the DO11 TCR transgene, which is cross-reactive with I-Ab,
plus null alleles of either CD40, CD40L, c-Rel, or IkBa (DN), a dominant
negative inhibitor of NF-kB. Transfer of cells from these animals into
Balb/c recipients of C57Bl6 cardiac grafts will provide a means to
examine in vivo and in vitro the molecular mechanisms governing
CD40/CD40L costimulatory effects. Aim 1 will determine the role of CD40
ligand signals on T cell activation, proliferation, unresponsiveness,
and cytokine secretion. Aim 2 will determine the cellular mechanisms by
which CD40 expressed on T cells regulates allograft rejection by
mechanisms of activation and apoptosis involving FasL and TNF-a signals.
Aim 3 will investigate the molecular mechanisms by which activation of
NFkB controls allograft survival.
描述:(改编自申请人摘要)
移植后,急性排斥反应被认为是最常见的并发症。
频繁的严重并发症和慢性的最佳预测
排斥反应是长期移植物丢失的主要原因。T细胞至关重要
引发和维持急性排斥反应早期干预
移植排斥反应需要了解T细胞的机制,
激活,与同种异体移植物存活有关。主要研究者
其他人发现,阻断CD 40信号通路,
生存这项提案的目标是确定哪些CD 40调节
功能介导移植物排斥。CD 40信号由两种细胞转导。
NF-κ B依赖和非依赖机制。PI发现,在
用显性负转基因体内抑制NF-κ B活化
或通过c-Rel基因缺失导致同种异体移植物存活。因此,一个焦点
将是对CD 40的作用调节的行动是NF-κ B依赖。
研究者提出了一种假设,即阻断CD 40/CD 40 L,
共刺激通路通过NF-κ B依赖性抑制同种异体移植物存活
机制等为了验证这一假设,他们将雇用一名收养的
双转基因心脏移植模型的建立
表达DO 11 TCR转基因,其与I-Ab交叉反应,
加上CD 40、CD 40 L、c-Rel或IkBa(DN)的无效等位基因,
NF-kB的负性抑制剂。将这些动物的细胞转移到
C57 B16心脏移植物的Balb/c受体将提供一种手段,
在体内和体外研究控制
CD 40/CD 40 L共刺激作用。目的1将确定CD 40的作用
配体信号对T细胞活化、增殖、无反应性
和细胞因子分泌。目标2将确定细胞机制,
T细胞上表达的CD 40通过以下方式调节同种异体移植物排斥反应:
涉及FasL和TNF-α信号的活化和凋亡机制。
目的3将研究激活的分子机制,
NFkB控制同种异体移植物存活。
项目成果
期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Differentiation of stress, metabolism, communication, and defense responses following transplantation.
移植后应激、新陈代谢、交流和防御反应的分化。
- DOI:10.1189/jlb.0102052
- 发表时间:2003
- 期刊:
- 影响因子:5.5
- 作者:Mueller,ThomasF;Ma,Chunyan;Lederer,JamesA;Perkins,DavidL
- 通讯作者:Perkins,DavidL
Analysis of cytokine functions in graft rejection by gene expression profiles.
通过基因表达谱分析移植排斥中细胞因子的功能。
- DOI:10.1097/01.tp.0000093464.72920.7c
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:Liang,Yurong;Christopher,Kenneth;DeFina,Rachel;Cidado,Justin;He,Hongzhen;Haley,KathleenJ;Finn,PatriciaW;Perkins,DavidL
- 通讯作者:Perkins,DavidL
Analysis of immunoglobulin and T-cell receptor gene deficiency in graft rejection by gene expression profiles.
通过基因表达谱分析移植排斥反应中免疫球蛋白和 T 细胞受体基因缺陷。
- DOI:10.1097/01.tp.0000113803.45613.f8
- 发表时间:2004
- 期刊:
- 影响因子:6.2
- 作者:DeFina,RachelA;Liang,Yurong;He,Hongzhen;Haley,KathleenJ;Christopher,Kenneth;Finn,PatriciaW;Perkins,DavidL
- 通讯作者:Perkins,DavidL
Molecular profiling of the role of the NF-kappaB family of transcription factors during alloimmunity.
转录因子 NF-kappaB 家族在同种免疫过程中作用的分子谱分析。
- DOI:
- 发表时间:2002
- 期刊:
- 影响因子:0
- 作者:Finn,PatriciaW;He,Hongzhen;Ma,Chunyan;Mueller,Thomas;Stone,JamesR;Liou,Hsiou-Chi;Boothby,MarkR;Perkins,DavidL
- 通讯作者:Perkins,DavidL
Analysis of costimulation by 4-1BBL, CD40L, and B7 in graft rejection by gene expression profiles.
通过基因表达谱分析移植排斥中 4-1BBL、CD40L 和 B7 的共刺激。
- DOI:10.1007/s00109-003-0468-1
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:DeFina,Rachel;Christopher,Kenneth;He,Hongzhen;Mandelbrot,Didier;Gu,Yongping;Finn,Patricia;Perkins,DavidL
- 通讯作者:Perkins,DavidL
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Linn Perkins其他文献
David Linn Perkins的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Linn Perkins', 18)}}的其他基金
Transplantation: Graft Cell Promotion of Rejection
移植:移植细胞促进排斥反应
- 批准号:
6745731 - 财政年份:2004
- 资助金额:
$ 27.54万 - 项目类别:
PERIPHERAL T CELL TOLERANCE INDUCED BY SUPERANTIGENS
超抗原诱导的外周 T 细胞耐受
- 批准号:
3455881 - 财政年份:1991
- 资助金额:
$ 27.54万 - 项目类别:
PERIPHERAL T-CELL TOLERANCE INDUCED BY SUPERANTIGENS
超抗原诱导的外周 T 细胞耐受
- 批准号:
2066495 - 财政年份:1991
- 资助金额:
$ 27.54万 - 项目类别:
PERIPHERAL T CELL TOLERANCE INDUCED BY SUPERANTIGENS
超抗原诱导的外周 T 细胞耐受
- 批准号:
3455879 - 财政年份:1991
- 资助金额:
$ 27.54万 - 项目类别:
PERIPHERAL T-CELL TOLERANCE INDUCED BY SUPERANTIGENS
超抗原诱导的外周 T 细胞耐受
- 批准号:
2066496 - 财政年份:1991
- 资助金额:
$ 27.54万 - 项目类别:
相似海外基金
Regulation of T lymphocyte apoptosis by GIMAP5
GIMAP5对T淋巴细胞凋亡的调节
- 批准号:
183041 - 财政年份:2009
- 资助金额:
$ 27.54万 - 项目类别:
Studentship Programs
Apoptosis, Signaling Defects and T Lymphocyte Homeostasis in Patients with Cancer
癌症患者的细胞凋亡、信号传导缺陷和 T 淋巴细胞稳态
- 批准号:
7116658 - 财政年份:2006
- 资助金额:
$ 27.54万 - 项目类别:
T Lymphocyte Apoptosis in Hepatitis C Persistence
丙型肝炎持续存在中的 T 淋巴细胞凋亡
- 批准号:
6778153 - 财政年份:2002
- 资助金额:
$ 27.54万 - 项目类别:
T Lymphocyte Apoptosis in Hepatitis C Persistence
丙型肝炎持续存在中的 T 淋巴细胞凋亡
- 批准号:
6929713 - 财政年份:2002
- 资助金额:
$ 27.54万 - 项目类别:
T Lymphocyte Apoptosis in Hepatitis C Persistence
丙型肝炎持续存在中的 T 淋巴细胞凋亡
- 批准号:
6544560 - 财政年份:2002
- 资助金额:
$ 27.54万 - 项目类别:
T Lymphocyte Apoptosis in Hepatitis C Persistence
丙型肝炎持续存在中的 T 淋巴细胞凋亡
- 批准号:
6615695 - 财政年份:2002
- 资助金额:
$ 27.54万 - 项目类别:
T Lymphocyte Apoptosis in Hepatitis C Persistence
丙型肝炎持续存在中的 T 淋巴细胞凋亡
- 批准号:
7095934 - 财政年份:2002
- 资助金额:
$ 27.54万 - 项目类别:
Apoptosis Signaling in T Lymphocyte Leukemia Cells Induced by the TCR/CD3 Complex
TCR/CD3 复合物诱导 T 淋巴细胞白血病细胞的凋亡信号转导
- 批准号:
5222944 - 财政年份:2000
- 资助金额:
$ 27.54万 - 项目类别:
Research Grants
Apoptosis, Signaling Defects and T Lymphocyte Homeostasis in Patients with Cancer
癌症患者的细胞凋亡、信号传导缺陷和 T 淋巴细胞稳态
- 批准号:
7903454 - 财政年份:
- 资助金额:
$ 27.54万 - 项目类别:
Apoptosis, Signaling Defects and T Lymphocyte Homeostasis in Patients with Cancer
癌症患者的细胞凋亡、信号传导缺陷和 T 淋巴细胞稳态
- 批准号:
8121425 - 财政年份:
- 资助金额:
$ 27.54万 - 项目类别:














{{item.name}}会员




